Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Romance00on Apr 21, 2018 9:27pm
325 Views
Post# 27922548

Investor Relations

Investor RelationsI've been in touch with investor relations at the end of the day yesterday... This was my reply. Cheers...



Thank you for your interest in and continued support of Aphria.

We appreciate all emails for our investors regardless of topic.

The general market has been down on cannabis stocks for the last couple of month but our stock has experienced more selling pressure that the others. To address this, we have been out raising interest with institutional shareholders and have released a number of press releases detailing our current activities, including releasing our strong Q3 results on Monday.

Our expansion projects remain on budget and on time and we will have a significant levels of products available for start of adult use in the fall.

We also continue to execute on Aphria International’s strategic plan. Our GMP certifications to export to Germany, Italy and Malta are close to completion and we believe we will have our first commercial international shipments by the end of the summer.

Carl A. Merton
Aphria Inc.


Bullboard Posts